Single User License: Antisense And RNAi Therapeutics Market - USD 4315.5 Flat 10% Discount!! Global Industry Analysis, Size, Share, Free Customization as per your requirement Growth, Trends And Forecast 2015 - 2023 You will get Custom Report at Syndicated Report
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
price Report will be delivered with in 15-20 working days
Request Sample
Buy Now
REPORT DESCRIPTION
Increasing prevalence of cardiac diseases, coronary artery diseases, neurodegenerative and infectious diseases are the key factors that are anticipated to fuel the market growth. Antisense and RNAi technologies helps in understanding the mechanism of genes related to turning on and off in cells.RNAi is a gene silencing process in which RNA molecules inhibit the expression of molecule by destructing mRNA. miRNA and siRNA are mainly two types of RNA used in destruction of mRNA. Whereas, antisense therapy involve synthesis of a strand of nucleic acid (DNA or RNA) that would further bind to mRNA and inactivate.RNAi and antisense therapeutics inhibit the gene expression by natural mechanism therefore, the technologies have huge scope for the treatment of various diseases such as neurodegenerative disorders and cancer(colorectal cancer, pancreatic cancer, malignant melanoma, malignant glioma). These technologies are being used majorly by research institutes and pharmaceutical companies. Browse Full Report with TOC : http://www.transparencymarketresearch.com/antisense-rnai-therapeuticsmarket.html The antisense and RNAi therapeutics market could be categorized based on therapeutic applications and technology. The therapeutic segment of the market could further be segmented into ocular diseases, infectious diseases, kidney diseases, neurodegenerative diseases, cancer, lung disorder, genetic disorder and respiratory disorder. The RNAi technology could be further analyzed based on siRNA and miRNA. In the therapeutics segment, infectious disease are expected to witness highest growth rate during the forecast period due to rising incidence of infectious disease such as AIDS. The market for antisense and RNAi therapeutics can also be subdivided into different end users such as pharmaceutical industry, therapeutics and research institutes. Presently, research institutes primarily utilize RNA technology for the development of RNA drugs, thereby accounting for the largest market share. North America, Latin America, Asia Pacific, Europe and MEA are the major geographies for the antisense and RNAi therapeutics market. Currently, North America accounted for the largest market share in terms of revenue generation, due to increasing prevalence of neurodegenerative and cardiovascular disease and increasing awareness among the patient population for the usage of RNA therapeutics. However, Asia Pacific is anticipated to emerge asthefastest growing region in RNAi and antisense therapeutic market because of increasing population base and improving health care facilities. The antisense and RNAi therapeutics market is witnessing substantial number of strategic collaboration and licensing activities by the pharmaceutical and biotechnological companies. Hence, increasing number of collaboration among the organizations are expected to pull the growth of global antisense and RNAi therapeutics market. Increasing demand for advanced technology for efficient treatment, target specific gene suppression responsible for disease such as Alzheimer disease, Huntington disease and many more.With the usage of RNAi technique synthesis of disease causing protein even before they are made could be inhibited. In 2014,two antisense
drugs were approved by the U.S. Food and Drug Administration (FDA) namely Fomivirsen (Vitravene) for the treatment of cytomegalovirus retinitis and Mipomersen (Kynamro) for homozygous familial hypercholesterolemia. Moreover, as of 2014, 40 antisense and siRNA molecules were in clinical trials and in these over 20 drugs were in advance clinical trial (Phase II and III). Thus, presence of large number of RNAi molecules in clinical trials and their expected launch during the forecast period is expected to support the market growth. However, toxicity caused by RNAi and antisense based drugs (primarily liver toxicity) is the major challenge being witnessed by the market. Huge investment and high failure rate are also anticipated to restrain the growth of the industry. Browse More Pharmaceutical Market Report : http://www.transparencymarketresearch.com/pharmaceuticalmarket-reports-1.html Some of the major players operating in antisense and RNAi therapeutics market includes Sanofi S.A., Isis Pharmaceuticals, Tekmira PharmaceuticalsCorporation, AstraZeneca plc, Allergan, Inc., Antisense Therapeutics, Atlantic Pharmaceuticals Inc., Biogen Idec, Ascletis Innovation, Bristol-Myers Squibb, Dainippon SumitomoPharma, GlaxoSmithKline plc, Pfizer, Inc., Novartis AG and Alnylam Pharmaceuticals Inc. This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include: • • • • •
North America Asia Pacific Europe Middle East and Africa Latin America
This report provides comprehensive analysis of • Market growth drivers • Factors limiting market growth • Current market trends • Market structure • Market projections for upcoming years This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report • This report provides pin-point analysis for changing competitive dynamics • It provides a forward looking perspective on different factors driving or restraining market growth • It provides a six-year forecast assessed on the basis of how the market is predicted to grow • It helps in understanding the key product segments and their future • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments • It provides distinctive graphics and exemplified SWOT analysis of major market segments About Us : Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge. Inquiry Before Buying: http://www.transparencymarketresearch.com/antisense-rnai-therapeutics-market.html Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htm Latest Articles Reports: http://www.transparencymarketresearch.com/articles.htm Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/ Browse market research blog: http://tmrmarkets.blogspot.co.uk